SERA PROGNOSTICS, INC. Revenue from Contract with Customer, Excluding Assessed Tax
SERA PROGNOSTICS, INC. (SERA) reported Revenue from Contract with Customer, Excluding Assessed Tax of $30.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-12
- SERA PROGNOSTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $30.00K, a 76.47% increase year-over-year.
- SERA PROGNOSTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $14.00K, a 63.16% decline year-over-year.
- SERA PROGNOSTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $10.00K, a 58.33% decline year-over-year.
- SERA PROGNOSTICS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $16.00K, a 44.83% decline year-over-year.
- SERA PROGNOSTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $81.00K, a 5.19% increase from fiscal 2024.
- SERA PROGNOSTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $77.00K, a 74.84% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $306.00K, a 14.18% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $268.00K, a 226.83% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.00K 10-Q · filed 2026-08-12 | $44.00K 10-Q · filed 2026-08-12 | $54.00K derived: sum of 3 quarters · filed 2026-08-12 | $70.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $14.00K 10-Q · filed 2026-05-06 | $24.00K derived: sum of 2 quarters · filed 2026-05-06 | $40.00K derived: sum of 3 quarters · filed 2026-05-06 | $57.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $26.00K derived: sum of 2 quarters · filed 2026-03-18 | $43.00K derived: sum of 3 quarters · filed 2026-08-12 | $81.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $16.00K 10-Q · filed 2025-11-13 | $33.00K derived: sum of 2 quarters · filed 2026-08-12 | $71.00K 10-Q · filed 2025-11-13 | $95.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $17.00K 10-Q · filed 2026-08-12 | $55.00K 10-Q · filed 2026-08-12 | $79.00K derived: sum of 3 quarters · filed 2026-08-12 | $108.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $38.00K 10-Q · filed 2026-05-06 | $62.00K derived: sum of 2 quarters · filed 2026-05-06 | $91.00K derived: sum of 3 quarters · filed 2026-05-06 | $115.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $53.00K derived: sum of 2 quarters · filed 2026-03-18 | $77.00K derived: sum of 3 quarters · filed 2026-03-18 | $77.00K 10-K · filed 2026-03-18 |
| 2024-09-30 | $29.00K 10-Q · filed 2025-11-13 | $53.00K derived: sum of 2 quarters · filed 2025-11-13 | $53.00K 10-Q · filed 2025-11-13 | $94.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $24.00K 10-Q · filed 2025-08-06 | $24.00K 10-Q · filed 2025-08-06 | $65.00K derived: sum of 3 quarters · filed 2025-08-06 | $107.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | $41.00K derived: sum of 2 quarters · filed 2025-05-07 | $83.00K derived: sum of 3 quarters · filed 2025-05-07 | $206.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $83.00K derived: sum of 2 quarters · filed 2025-03-19 | $206.00K derived: sum of 3 quarters · filed 2025-03-19 | $306.00K 10-K · filed 2025-03-19 |
| 2023-09-30 | $42.00K 10-Q · filed 2024-11-06 | $165.00K derived: sum of 2 quarters · filed 2024-11-06 | $265.00K 10-Q · filed 2024-11-06 | $330.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $123.00K 10-Q · filed 2024-08-07 | $223.00K 10-Q · filed 2024-08-07 | $288.00K derived: sum of 3 quarters · filed 2024-08-07 | $375.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-08 | $165.00K derived: sum of 2 quarters · filed 2024-05-08 | $252.00K derived: sum of 3 quarters · filed 2024-05-08 | $330.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $152.00K derived: sum of 2 quarters · filed 2024-03-20 | $230.00K derived: sum of 3 quarters · filed 2024-03-20 | $268.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $87.00K 10-Q · filed 2023-11-08 | $165.00K derived: sum of 2 quarters · filed 2023-11-08 | $203.00K 10-Q · filed 2023-11-08 | $229.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $78.00K 10-Q · filed 2023-08-09 | $116.00K 10-Q · filed 2023-08-09 | $142.00K derived: sum of 3 quarters · filed 2023-08-09 | $165.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $38.00K 10-Q · filed 2023-05-10 | $64.00K derived: sum of 2 quarters · filed 2023-05-10 | $87.00K derived: sum of 3 quarters · filed 2023-05-10 | $107.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $49.00K derived: sum of 2 quarters · filed 2023-03-22 | $69.00K derived: sum of 3 quarters · filed 2023-03-22 | $82.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $23.00K 10-Q · filed 2022-11-09 | $43.00K derived: sum of 2 quarters · filed 2022-11-09 | $56.00K 10-Q · filed 2022-11-09 | $62.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $20.00K 10-Q · filed 2022-08-10 | $33.00K 10-Q · filed 2022-08-10 | $39.00K derived: sum of 3 quarters · filed 2022-08-10 | $44.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $13.00K 10-Q · filed 2022-05-10 | $19.00K derived: sum of 2 quarters · filed 2022-05-10 | $24.00K derived: sum of 3 quarters · filed 2022-05-10 | $30.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $11.00K derived: sum of 2 quarters · filed 2022-03-29 | $17.00K derived: sum of 3 quarters · filed 2022-03-29 | $25.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $5.00K 10-Q · filed 2021-11-09 | $11.00K derived: sum of 2 quarters · filed 2021-11-09 | $19.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $6.00K 10-Q · filed 2021-08-30 | $14.00K 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |